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INT ROD UCT ION
Lysosomes are cytoplasmic membrane–enclosed organelles 
filled with numerous acidic hydrolases. These organelles are 
dynamic and can fuse with a variety of vesicles to mediate 
degradation of extracellular materials that have been endo-
cytosed or intracellular components that have been seques-
tered by autophagy. Furthermore, lysosomes are recycled and 
reformed after fusion with cargo-containing vacuoles (Luzio 
et al., 2007; Yu et al., 2010). Fundamental cellular processes 
orchestrated by lysosomes require cathepsin proteases; dys-
regulation of these activities contributes to the develop-
ment of malignancy and Alzheimer’s disease (Gocheva et al., 
2006; Mueller-Steiner et al., 2006). Secretion of cathepsins 
from lysosomes is involved in lysosomal membrane perme-
abilization–mediated cell death via caspase-dependent and 
caspase-independent pathways (Kreuzaler et al., 2011; Aits and 
Jäättelä, 2013). In addition, lysosomal rupture and cytoplasmic 
release of cathepsin B triggered by phagocytosis of crystals lead 
to activation of the NLRP3 inflammasome and maturation of 
the proinflammatory cytokines IL-1β and IL-18, which are 
key events linked to the development of atherosclerosis and 
Alzheimer’s disease (Halle et al., 2008; Duewell et al., 2010).
Certain lysosomal proteases also provide antimicrobial 
host defense against infection. Lysosomal acidic hydrolases, 
especially cathepsins, are executioner proteases used for deg-
radation of intracellular bacteria within lysosomes. Macro-
phages lacking cathepsin D have a reduced capacity to kill 
bacteria during pneumococcal infection (Bewley et al., 2011). 
Similarly, mice with a genomic deletion of cathepsin E have 
increased susceptibility to infection by Staphylococcus aureus 
and Porphyromonas gingivalis (Tsukuba et al., 2006). Fur-
thermore, a protective role for cathepsin L has been reported 
for Mycoplasma pulmonis infection (Xu et al., 2013). How-
ever, the relative contribution of different members within 
this large protease family in antibacterial host defense is 
largely underappreciated.
Here, we identified an important role for cathepsin B 
in driving increased susceptibility to the cytosolic patho-
gen Francisella novicida but not to the vacuolar-restricted 
pathogen Salmonella enterica serovar Typhimurium (S. Ty-
phimurium). Genetic deletion or pharmacological inhibi-
tion of cathepsin B triggered signaling via down-regulation 
of mechanistic target of rapamycin (mTOR) and the lyso-
somal calcium channel TRP ML1 to activate transcription 
factor EB (TFEB), which in turn results in increased lyso-
somal biogenesis and autophagy to mediate clearance of the 
bacteria. This phenomenon was not observed with genetic 
deletion of cathepsin G, elastase, or elastase and neutrophil 
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proteinase 3. Our results, therefore, identified a fundamental 
negative regulatory function of cathepsin B in the host cell 
against F. novicida infection.
RES ULTS
Cathepsin B negatively regulates host defense 
against F. novicida infection
Intracellularly replicating bacterial pathogens have evolved 
strategies to evade degradation by lysosomes to survive and 
replicate in the hostile environment of the host cell (Ray et 
al., 2009; Huang and Brumell, 2014). F. novicida escapes the 
vacuole to undergo replication in the cytoplasm of infected 
cells, whereas S. Typhimurium replicates inside S. enterica–
containing vacuoles. Despite decades of research on cathep-
sin biology, the role of lysosomal cathepsins in host defense 
against intracellularly replicating bacterial pathogens with dis-
tinct intracellular lifestyles has remained enigmatic. To address 
this, WT mice and mice deficient in the lysosomal cathepsin 
B, cathepsin G, or the extralysosomal proteases elastase and 
neutrophil proteinase 3 were infected with F. novicida or S. 
Typhimurium, and survival was monitored over time. Mice 
of all genotypes succumbed with similar kinetics to S. Ty-
phimurium infection with most animals dying within 8 d 
after infection (Fig. 1 A). In contrast, when infected with F. 
novicida, cathepsin B–deficient mice (Ctsb−/− mice) were sig-
nificantly protected from lethality, with 65% of animals from 
this group surviving beyond day 10, compared with only 25% 
of WT mice (Fig.  1 B). Enhanced resistance to F. novicida 
infection was specific to Ctsb−/− mice because mice lacking 
cathepsin G, elastase, or elastase and neutrophil proteinase 3 
died with similar kinetics as WT mice (Fig. 1 B).
Reduced mortality in Ctsb−/− mice could be caused 
by reduced bacterial burden. Therefore, we determined the 
number of bacteria in the spleen and liver of WT and Ctsb−/− 
mice after 1 and 3 d of infection with F. novicida. Bacterial 
loads in the liver and spleen of Ctsb−/− mice were significantly 
lower than those in WT mice on day 3 but not on day 1 after 
infection (Fig.  1, C and D). In agreement, less granulomas 
were formed in the liver of infected Ctsb−/− mice relative to 
WT controls (Fig. 1 E). Reduced bacterial burden of Ctsb−/− 
mice on day 3 after infection was also associated with reduced 
production of proinflammatory cytokines and chemokines in 
the liver (Fig. 1 F). Moreover, cell death and associated acti-
vation of the apoptotic caspases 3, 7, and 8 was diminished 
in the liver tissue of Ctsb−/− mice 3 d after infection (Fig. 1, 
G and H). These results suggested cathepsin B plays negative 
roles in host defense against F. novicida infection.
Intracellular growth of F. novicida is suppressed  
by the lack of cathepsin B
Recruitment of immune cells and production of proinflam-
matory cytokines are hallmarks of effective innate immune 
responses to infection (Cowley and Elkins, 2011). One pos-
sibility is that the improved early innate immune response in 
Ctsb−/− mice might restrict bacterial replication or increase 
bacterial killing and clearance. Therefore, we investigated the 
number of circulating total white blood cells, red blood cells, 
neutrophils, and monocytes in the blood of uninfected WT 
and Ctsb−/− mice and WT and Ctsb−/− mice infected with 
F. novicida. Relative to their uninfected controls, both WT 
and Ctsb−/− mice exhibited a global reduction in the num-
bers of circulating white blood cells (lymphocytes and my-
eloid cells) and monocytes and an increase in the number 
of neutrophils 24 h after F. novicida infection, whereas total 
red blood cell counts remained unchanged (Fig. 2 A). These 
results suggested that certain populations of circulating im-
mune cells might have migrated from the BM to the sites of 
infection. However, no significant differences were noted in 
the prevalence of specific immune cell populations in cir-
culation between infected WT and Ctsb−/− mice (Fig. 2 A). 
We also did not observe any difference in the number of 
CD11b+ Ly6g+ neutrophils and CD11b+ Ly6g− monocyte 
populations in the liver and spleen of WT and Ctsb−/− mice 
24 h after F. novicida infection when WT and Ctsb−/− mice 
have comparable bacterial burden in the liver and spleen 
(Fig.  2 B). Finally, the levels of the proinflammatory cyto-
kines TNF, IL-1β, and IL-6 and the keratinocyte-derived 
chemokine (CXCL1) in liver and spleen of infected WT and 
Ctsb−/− mice were similar after 24 h of infection (Fig. 2 C), 
suggesting that cathepsin B controlled host defense against 
F. novicida independently of immune cell recruitment and 
cytokine or chemokine production.
Macrophages play a key role in controlling intracellu-
lar replication and dissemination of F. novicida (Hall et al., 
2008). To investigate the role of cathepsin B in the control 
of F. novicida replication in macrophages, we infected pri-
mary BMDMs from WT and Ctsb−/− mice with F. novicida 
and determined the number of intracellular bacteria over 
time. Notably, Ctsb−/− BMDMs cleared bacteria more effi-
ciently relative to WT BMDMs at 8 and 24 h after infection 
(Fig. 2 D). In agreement, inhibition of the cathepsin B pro-
tease activity with CA-074 methyl ester (Me) also enhanced 
the bactericidal activity of WT BMDMs (Fig. 2 E).
F. novicida infection in macrophages is detected by the 
DNA-sensing AIM2 inflammasome (Fernandes-Alnemri et 
al., 2010; Jones et al., 2010; Rathinam et al., 2010; Man et al., 
2016), but cathepsin B was not required for AIM2-dependent 
activation of caspase 1, the subsequent release of the caspase 
1 substrate IL-1β, and pyroptotic cell death in BMDMs in-
fected with F. novicida (Fig. 3, A–C). Other members of the 
caspase family also contribute to innate immunity during 
infection (Man and Kanneganti, 2016). However, infected 
Ctsb−/− BMDMs displayed similar levels of caspases 3, 7, and 
8 activation compared with infected WT BMDMs, in agree-
ment with results from CA-074 Me–pretreated WT BMDMs 
(Fig.  3 D). Differential activation of apoptotic caspases was 
also not observed in liver tissues from WT and Ctsb−/− mice 
after 24 h of infection (Fig. 3 E).
Apart from inflammasome signaling, type I interferons, 
inducible nitric oxide synthase (iNOS), and antimicrobial 
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Figure 1. Ctsb−/−mice are resistant to F. novicida infection. (A) WT and mutant mice were infected i.p. with 5 × 103 CFU of S. Typhimurium, and survival 
was monitored. (B) WT and mutant mice were infected subcutaneously with 1.5 × 105 CFU of F. novicida, and survival was monitored. (C and D) WT and 
Ctsb−/− mice were infected with 1.5 × 105 CFU of F. novicida. Bacterial burden in liver (C) and spleen (D) on days 1 and 3 was measured. (E) Liver sections 
from WT and Ctsb−/− mice infected with F. novicida (day 3) were stained with MPO. Quantification of MPO-stained granuloma and the number of granuloma 
per field are shown. (F) Proinflammatory cytokine and chemokine levels were measured in the liver from WT and Ctsb−/− mice on day 3 after infection with 
F. novicida. G-CSF, granulocyte CSF; KC, keratinocyte-derived chemokine. (G) TUN EL staining and cleaved caspase 3 (Casp-3) staining of liver sections from 
WT and Ctsb−/− mice after infection with F. novicida for 3 d (D3). (H) Liver tissue samples from WT and Ctsb−/− mice after infection with F. novicida for 3 d 
were homogenized, and lysates were analyzed for caspases 8, 3, and 7 activation by immunoblotting analysis. Each symbol indicates an individual mouse 
for C, D, and F. Data represent means ± SEM. Results are pooled from three independent experiments for A–D and are representative of two independent 
experiments for E–H. Bars, 100 µm. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. ns, not significant.
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peptides regulate host protection against F. novicida infec-
tion (Lindgren et al., 2005; Henry et al., 2007). However, 
WT and Ctsb−/− BMDMs that have been infected with 
F. novicida expressed similar transcript levels of Ifnb, iNos, 
and the antimicrobial glycoprotein lipocalin 2 (Lcn2; 
Fig. 3 F). Also, the levels of activated NF-κB and extracel-
lular signal–regulated kinase (ERK) as well as production of 
IL-6 and TNF were not differentially regulated in F. novi-
cida–infected WT and Ctsb−/− BMDMs (Fig. 3, G and H). 
These data collectively suggested that the role of cathepsin 
B in the regulation of F. novicida replication is uncoupled 
from macrophage cell death, inflammasome activation, and 
inflammatory cytokine production.
Lysosomes target F. novicida in the absence of cathepsin B
Fusion of lysosomes with pathogen-occupied vacuoles is a 
major bactericidal mechanism in macrophages (Roy et al., 
2006). In response, bacterial pathogens have evolved mech-
anisms to evade the lysosomal degradation pathway. During 
F. novicida infection, bacteria escape the vacuoles of human 
Figure 2. Macrophages lacking cathepsin B have enhanced bactericidal activity. (A) Blood cells from uninfected mice (d 0) or mice infected with 
F. novicida (d 1) were analyzed for different cell populations with a Forcyte hematology analyzer. WBC, white blood cell. (B) On day 1 after F. novicida in-
fection, neutrophil (CD11b+ Ly6g+; Neu) and monocyte (CD11b+ Ly6g−; Mono) infiltration into the liver and spleen were analyzed. (C) Cytokine levels were 
measured in the liver and spleen from WT and Ctsb−/− mice on day 1 after infection with F. novicida. (D) BMDMs from WT and Ctsb−/− mice were infected 
with F. novicida (MOI 10) for 3 h, and numbers of intracellular bacteria were enumerated at the indicated times. (E) BMDMs from WT mice were infected 
with F. novicida (MOI 10) for 3 h in media (Med) with or without the cathepsin B inhibitor CA-074 Me (5 µM). The number of intracellular bacteria was 
enumerated at the indicated times. KC, keratinocyte-derived chemokine. Each symbol indicates an individual mouse and means ± SEM are shown. Data are 
representative of two independent experiments for A–C or three independent experiments for D and E. *, P < 0.05; **, P < 0.01. ns, not significant.
o
n
 N
ovem
ber 3, 2016
D
ow
nloaded from
 
Published August 22, 2016
2085JEM Vol. 213, No. 10
macrophages after 3–4 h of infection (Santic et al., 2005; Cle-
mens et al., 2009). To investigate whether improved control 
of F. novicida replication in the absence of cathepsin B was 
caused by increased fusion of F. novicida–containing vacuoles 
with lysosomes, we examined colocalization of a GFP-ex-
pressing strain of F. novicida with LysoTracker in infected WT 
and Ctsb−/− BMDMs. We found a significantly elevated fre-
quency of F. novicida colocalizing with lysosomes in Ctsb−/− 
BMDMs compared with the numbers observed in WT 
BMDMs at 5 h (67.2 ± 1.8% vs. 51.1 ± 2.2%) and 12 h (94.8 
± 0.4% vs. 86.8 ± 0.9%) after infection (Fig. 4, A–D). These 
results suggested that the prevalence of lysosome-associated F. 
novicida increased in Ctsb−/− BMDMs compared with WT 
BMDMs. In agreement, treatment of WT BMDMs with a 
cathepsin B protease inhibitor CA-074 Me significantly in-
creased the prevalence of LysoTracker-positive F. novicida 
(Fig. 4 E). Notably, we observed that Ctsb−/− BMDMs con-
tained significantly more LysoTracker-positive vacuoles be-
fore infection, and the number of LysoTracker puncta in 
uninfected Ctsb−/− BMDMs was nearly twofold that of WT 
BMDMs (15.9 ± 0.5 vs. 8.3 ± 0.3 per cell; Fig. 4, F and G). 
The increased prevalence of LysoTracker-positive vacuoles 
and increased expression of the lysosomal membrane protein 
LAMP1 in Ctsb−/− BMDMs was further confirmed by flow 
cytometry and immunoblotting analysis, respectively (Fig. 4, 
H–K). Similar to Ctsb−/− BMDMs, the cathepsin B inhibi-
tor CA-074 Me increased the number of LysoTracker puncta 
and expression of LAMP1 in WT BMDMs (Fig. 4, L–N).
Figure 3. Cathepsin B is dispensable for 
caspase activation and NF-κB and ERK 
signaling in response to F. novicida infec-
tion. (A–C) Immunoblot analysis of caspase 1 
(Casp-1) and its subunit P20 (A) and analysis 
of IL-1β release (B) and cell death (C) in WT, 
Ctsb−/−, and Aim2−/− BMDMs infected with F. 
novicida (MOI 100) for 20 h. (D) Immunoblot 
analysis of caspases 1, 3, 7, and 8 in WT and 
Ctsb−/− BMDMs infected with F. novicida (MOI 
100) for 20 h with or without 5 µM CA-074 Me 
(CA). Uninfected cells were used as negative 
controls. Arrows indicate the cleaved forms. 
(E) Liver homogenates from WT and Ctsb−/− 
mice after infection with F. novicida for 24 h 
were analyzed for caspases 8, 7, and 3 activa-
tion by immunoblotting analysis. Arrows indi-
cate the cleaved forms. (F) Expression of the 
genes encoding IFN-β, iNOS, and Lcn2 was an-
alyzed in WT and Ctsb−/− BMDMs infected with 
F. novicida for the indicated times by quanti-
tative real-time PCR. (G) BMDMs from WT and 
Ctsb−/− mice were infected with F. novicida 
(MOI 100; F.n.) for the indicated times, and cell 
lysates were analyzed for phosphorylated and 
total ERK and IκBα proteins by immunoblot-
ting analysis. (H) Production of IL-6 and TNF 
was detected in uninfected or F. novicida–in-
fected WT and Ctsb−/− BMDMs. Data are rep-
resentative of three independent experiments 
and are means ± SEM. ***, P < 0.001. Med, 
uninfected; ns, not significant.
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Figure 4. Recruitment of the lysosome to F. novicida is accelerated in the absence of cathepsin B. (A and C) BMDMs from WT and Ctsb−/− mice 
were infected with GFP-expressing F. novicida (MOI 20; F.n.) for 5 h (A) or 12 h (C) followed by labeling with 100 nM LysoTracker for 30 min. Fixed samples 
were processed for confocal microscopy. Arrowheads indicate lysosome-targeted F. novicida; arrows indicate F. novicida free from lysosome colocalization. 
(B and D) Quantification of A (B) and C (D) are shown. At least 220 cells were analyzed for each group. (E) Quantification of the percentage of F. novicida 
colocalized with lysosomes in WT BMDMs infected with GFP-expressing F. novicida (MOI 20) for 5 h in the presence or absence (Med) of 5 µM CA-074 Me 
(CA). At least 200 cells were analyzed for each group. (F) Confocal microscopy analysis of WT and Ctsb−/− BMDMs stained with cathepsin B antibody (top) 
or labeled with LysoTracker (bottom). Insets indicate enlarged images. (G) Quantification of lysosomes in WT and Ctsb−/− BMDMs. Each symbol indicates an 
individual cell. At least 500 cells were analyzed for each group. (H) FACS analysis of WT and Ctsb−/− BMDMs stained with LysoTracker. (I) Confocal microscopy 
showing LAMP1 staining in WT and Ctsb−/− BMDMs. Insets indicate enlarged images. (J) Cell lysates from WT and Ctsb−/− BMDMs were analyzed for LAMP1 
protein expression by immunoblotting. (K) Quantification of the relative protein level of LAMP1 in J. (L) Representative images of WT BMDMs treated with 
or without cathepsin B inhibitor (5 µM CA-074 Me) for 12 h and labeled with LysoTracker. (M) FACS analysis of LysoTracker staining in WT BMDMs in the 
presence or absence of 5 µM CA-074 Me for 12 h. (N) Immunoblot analysis of LAMP1 expression in WT BMDMs in media or treated with 5 µM CA-074 Me 
for 12 h. Data are representative of three independent experiments and are means ± SEM. Bars, 10 µm. **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. MFI, 
mean fluorescence intensity.
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Transmission electron microscopy reveled that unin-
fected Ctsb−/− BMDMs contained larger single-membrane 
lysosomes and double-membrane autophagosomes compared 
with that in uninfected WT BMDMs (Fig. 5, A and C). Re-
markably, higher resolution analysis of these micrographs re-
vealed increased accumulation of partially digested vesicles in 
autolysosomes of Ctsb−/− BMDMs (Fig. 5 B), suggesting im-
paired nutrient recycling by Ctsb−/− lysosomes. Collectively, 
these results indicated that the enhanced antimicrobial activity 
of Ctsb−/− BMDMs to F. novicida might be attributed to their 
increased lysosomal biogenesis, which may result in increased 
efficiency in delivering the bacteria to lysosomes for killing.
Lysosomal biogenesis and autophagy are elevated  
in the absence of cathepsin B
We performed genome-wide expression analysis to profile 
differentially expressed genes in uninfected WT and Ctsb−/− 
BMDMs to examine whether the increased number of lyso-
somes in Ctsb−/− BMDMs is caused by enhanced lysosomal 
biogenesis. We identified increased expression of the gene en-
coding the TFEB and differentially regulated genes involved 
in the Coordinated Lysosomal Expression and Regulation 
(CLE AR) network as well as genes encoding lysosomal hy-
drolases, lysosomal membrane proteins, lysosomal acidifica-
tion proteins, and autophagy proteins (Fig. 6 A and Fig. S1; 
Palmieri et al., 2011). Importantly, autophagy and lysosomal 
biogenesis in response to starvation signals are up-regulated 
by the CLE AR gene network and its regulatory transcription 
factor TFEB (Sardiello et al., 2009; Settembre et al., 2011). 
Consistent with the increased expression of TFEB mRNA, 
we found a substantial increase in the protein expression level 
of TFEB in uninfected Ctsb−/− BMDMs relative to those of 
WT controls (Fig.  6  B). Activated TFEB translocates into 
the nucleus to drive transcription of genes encoding lyso-
somal proteins containing the CLE AR element (Sardiello 
et al., 2009). We indeed observed increased nuclear localiza-
tion of TFEB in Ctsb−/− BMDMs by immunofluorescence 
microscopy and immunoblotting analysis of TFEB (Fig.  6, 
C–E). These findings indicated that Ctsb−/− BMDMs have 
a superior capacity to drive lysosomal biogenesis by unleash-
ing the activity of TFEB.
Activation and nuclear localization of TFEB are tightly 
regulated by signaling via mTOR (Settembre et al., 2012). 
Activated mTOR retains TFEB in the cytoplasm by inducing 
phosphorylation of TFEB, whereas inhibition of mTOR results 
in activation and nuclear translocation of TFEB. We investigated 
whether the mechanism of increased TFEB activation in the 
absence of cathepsin B was caused by down-regulated mTOR 
activation. Remarkably, phosphorylation of both mTOR and 
its direct target 4E-BP were significantly diminished in un-
infected Ctsb−/− BMDMs compared with uninfected WT 
BMDMs (Fig. 6 F). We further confirmed this observation and 
found that WT BMDMs treated with CA-074 Me recapitu-
lated the results obtained in Ctsb−/− BMDMs (Fig. 6 F).
Figure 5. Cathepsin B deficiency results in impaired lysosomal 
recycling. (A) Transmission electron microscopy analysis of WT and Ctsb−/− 
BMDMs. Arrows in each inset indicate the single membrane lysosome– or 
double membrane autophagosome–associated vesicles. Dashed squares 
indicate a lysosome (Ly) or autophagosome (Au). (B) Undigested vesicles 
are accumulated in the autolysosomes of Ctsb−/− BMDMs. Arrows indi-
cate double membrane–enclosed vesicles, and arrowheads indicate single 
membrane–enclosed vesicles. (C) Quantification of the size of lysosomes 
and autophagosomes from WT and Ctsb−/− BMDMs. The diameters of more 
than 60 lysosomes and 30 autophagosomes were analyzed. Data are repre-
sentative of two independent experiments and are means ± SEM. Bars: (A) 
1 µm; (B) 0.5 µm. ***, P < 0.001.
o
n
 N
ovem
ber 3, 2016
D
ow
nloaded from
 
Published August 22, 2016
Cathespin B in lysosomal biogenesis and infection | Qi et al.2088
Figure 6. Cathepsin B restricts lysosomal biogenesis and autophagy. (A) Expression analysis of genes encoding cathepsin B, TFEB, WDR45, BECN1, 
ULK1, and cathepsin E in WT and Ctsb−/− BMDMs by quantitative real-time PCR. Ctse, cathepsin E; Hprt, hypoxanthine-guanine phosphoribosyltransferase. 
(B) Immunoblot analysis of TFEB, cathepsin B, and GAP DH (loading control) in uninfected WT and Ctsb−/− BMDMs. (C) Confocal microscopy analysis of 
TFEB staining in uninfected WT and Ctsb−/− BMDMs. (D) Percentage of nuclear localization of TFEB in uninfected WT and Ctsb−/− BMDMs. At least 200 cells 
were analyzed for each group. (E) Immunoblot analysis of TFEB in the nuclear and cytoplasmic fractions of uninfected WT and Ctsb−/− BMDMs (left) and 
the relative intensity of TFEB in nuclear versus cytoplasmic (right). Lamin B and GAP DH were used as quality controls for nuclear and cytoplasmic fractions 
separation, respectively. Quantification of the relative protein expression was processed using ImageJ. (F and G) Immunoblot analysis of phosphorylation of 
mTOR, 4EBP, AMPK, ULK1, and LC3-II in uninfected WT and Ctsb−/− BMDMs (left) or WT BMDMs in media (Med) with or without 5 µM CA-074 Me (CA) for 2 h. 
(H) Immunoblot analysis of proteins in F and G in WT BMDMs treated with 5 µM CA-074 Me for the indicated times. (I) Representative images of LysoTracker-labeled WT, 
Ctsb−/−, Ctsg−/−, Elastase−/−, Nepr3−/−, and cathepsin B inhibitor treated WT (WT_CA) BMDMs. (J) Immunoblot analysis of AMPK, ULK1, LC3, LAMP1, TFEB, and 
GAP DH (loading control) in uninfected WT, Ctsg−/−, Elastase−/−, and Nepr3−/− BMDMs. (C and I) Bars, 10 µm. Data are representative of three independent 
experiments and are means ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001. t-AMPK, total AMPK; t-mTOR, total mTOR.
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Inhibition of mTOR is mediated by the conserved sen-
sor of cellular energy and nutrient status, known as adenosine 
monophosphate–activated protein kinase (AMPK; Alers et al., 
2012). AMPK also directly activates ULK1 to induce the au-
tophagy pathway under stressed conditions (Kim et al., 2011). 
Notably, phosphorylation of both AMPK and ULK1 were 
substantially elevated in Ctsb−/− BMDMs (Fig. 6 G). More-
over, WT BMDMs treated with CA-074 Me phenocopied 
Ctsb−/− BMDMs (Fig. 6 G). To further confirm alterations in 
autophagy, we examined conversion of the autophagy marker 
LC3-I to the lipidated form of LC3-II. We indeed observed 
increased level of LC3-II in untreated Ctsb−/− BMDMs or in 
WT BMDMs treated with the cathepsin B inhibitor com-
pared with untreated WT BMDMs (Fig. 6 G).
Next, we examined which pathway governed by 
mTOR, AMPK, and TFEB was the apical signal initiating the 
increase in lysosomal biogenesis and autophagy. A time course 
experiment assessing WT BMDMs treated with CA-074 Me 
showed that LC3-II accumulation and reduction of phos-
phorylated mTOR occurred within 30 min of cathepsin B 
inhibition (Fig. 6 H). In line with reduced phosphorylation of 
mTOR, the expression of TFEB was induced after treatment 
with the inhibitor for 30 min (Fig. 6 H). Phosphorylation of 
AMPK and ULK1 increased after 2 h of treatment with the 
cathepsin B inhibitor (Fig. 6 H), suggesting that AMPK and 
ULK1 activation succeeded LC3-II accumulation, reduction 
of phosphorylated mTOR, and activation of TFEB. These re-
sults suggested that impaired lysosomal degradation and recy-
cling contributed to lysosomal biogenesis, whereas signaling 
via AMPK preferentially regulated the autophagy pathway 
and is not the apical signal driving increased lysosomal bio-
genesis in Ctsb−/− BMDMs. Importantly, we did not observe 
substantial differences in the number of lysosomes, phos-
phorylation of AMPK and ULK1, and protein expression 
of LC3-II, TFEB, and LAMP1 in Cathepsin G−/− (Ctsg−/−), 
Elastase−/−, or Nepr3−/− BMDMs compared with WT 
BMDMs (Fig. 6, I and J), suggesting that enhanced lysosomal 
biogenesis and autophagy are specific to Ctsb−/− BMDMs. 
Collectively, these results provided evidence to support that 
cathepsin B negatively regulated lysosomal biogenesis and 
autophagy at both the transcriptional and posttranslational 
levels through a mechanism that involved TFEB activation 
and ULK1 phosphorylation.
Cathepsin B down-regulates the TRP ML1 channel 
activity in the lysosome
Lysosomal ion channels and transporters play essential roles in 
regulating signals from the lysosome (Xu and Ren, 2015). For 
instance, the vacuolar ATPase, a key player in lysosome nutri-
ent sensing machinery, can sense lysosomal nutrient levels and 
regulate mTORC1 activity (Settembre et al., 2013). Calcium 
signaling mediated by the lysosomal calcium channel TRP 
ML1 (MCO LN1) regulates TFEB activity from the lysosome 
through the phosphatase calcineurin. Local calcineurin ac-
tivation via TRP ML1 is essential for nuclear translocation 
and activation of TFEB. The pathway regulating lysosomal 
biogenesis and autophagy seems to operate independently of 
mTOR (Medina et al., 2015). Previous studies have shown 
that cathepsin B mediates proteolytic cleavage of the lysosomal 
calcium flux channel TRP ML1 (Kiselyov et al., 2005) and that 
a loss of TRP ML1 induces leakage of cathepsin B into the 
cytoplasm (Colletti et al., 2012). It is possible that cathepsin B 
might mediate TRP ML1 channel activity to regulate TFEB 
activity. Indeed, the protein level of the full-length TRP ML1 
was increased in Ctsb−/− BMDMs, whereas differential lev-
els of the transcription of the gene encoding TRP ML1 was 
not observed between untreated WT and Ctsb−/− BMDMs 
(Fig. 7, A and B), suggesting decreased cleavage of TRP ML1 
in Ctsb−/− BMDMs. We enriched lysosome fractions from 
BMDMs to investigate the level of TRP ML1 cleavage. Cleav-
age of TRP ML1 in the lysosome was substantially impaired 
in untreated Ctsb−/− BMDMs compared with untreated WT 
BMDMs (Fig.  7  C). We further examined whether an in-
creased level of the full-length TRP ML1 protein in Ctsb−/− 
BMDMs resulted in altered Ca2+ efflux from the lysosome. 
WT and Ctsb−/− BMDMs were treated with the TRP ML1 
agonist ML-SA1 (Shen et al., 2012). We observed increased 
Ca2+ release from the lysosome in Ctsb−/− BMDMs stim-
ulated with ML-SA1 compared with treated WT BMDMs 
(Fig.  7  D). To further confirm whether lysosomal calcium 
signaling supported the increased TFEB activity in Ctsb−/− 
BMDMs, we treated Ctsb−/− BMDMs with the lysosomal 
TRP ML1 inhibitor PI(4,5)P2 (Zhang et al., 2012) and found 
that, over 8 h of inhibitor treatment, the expression of TFEB 
was substantially reduced in Ctsb−/− BMDMs (Fig. 7, E and 
F). Similar effects were observed in Ctsb−/− BMDMs treated 
with the calcineurin inhibitor cyclosporine A (Fig. 7, G and 
H). Collectively, these results suggested that cathepsin B neg-
atively regulated TFEB activity, in part through lysosomal cal-
cium signaling and degradation of TRP ML1.
Autophagy is up-regulated in the absence of cathepsin  
B during F. novicida infection
Autophagy has been previously shown to mediate reentry 
of cytosolic-dwelling F. novicida to the endocytic pathway 
and fusion with lysosomes (Checroun et al., 2006). To in-
vestigate how cathepsin B modulates lysosomal biogenesis 
and autophagy during F. novicida infection, WT and Ctsb−/− 
BMDMs were infected with F. novicida and analyzed for 
LC3+ puncta formation and TFEB expression. We found 
that F. novicida infection induced autophagy formation and 
significantly elevated the number of LC3+ puncta per cell 
in Ctsb−/− BMDMs compared with infected WT BMDMs 
(Fig. 8, A and B). Moreover, the size of LC3+ puncta in in-
fected Ctsb−/− BMDMs was markedly increased relative to 
those observed in infected WT BMDMs (Fig. 8 C). Notably, 
the frequency of autophagosome-associated F. novicida was 
significantly higher in Ctsb−/− BMDMs than in WT BMDMs 
(Fig.  8  D). Furthermore, we found an increased frequency 
of nuclear-localized TFEB in Ctsb−/− BMDMs compared 
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with WT BMDMs after F. novicida infection (Fig. 8, E and 
F). Accordingly, both mRNA and protein levels of TFEB 
in infected Ctsb−/− BMDMs were higher than that of in-
fected WT BMDMs (Fig. 8, G and H). We observed elevated 
phosphorylation of AMPK and ULK1 in Ctsb−/− BMDMs 
compared with their WT counterparts after F. novicida in-
fection (Fig. 8, H and I). In line with the observation of in-
creased phosphorylation of AMPK, the ratio of ADP to ATP 
in Ctsb−/− BMDMs was significantly higher than that of WT 
BMDMs after F. novicida infection (Fig. 8 J). Phosphorylated 
mTOR was further reduced in Ctsb−/− BMDMs infected 
with F. novicida (Fig. 8, H and I).
To further confirm that autophagy could play a pro-
tective role in the host defense against F. novicida infection, 
BMDMs from WT and autophagy-defective Atg7 −/− mice 
(Martinez et al., 2011) were infected with F. novicida and an-
alyzed for LC3 conversion and intracellular bacterial burden. 
Reduced LC3-II was observed in infected Atg7 −/− BMDMs 
relative to infected WT BMDMs (Fig. 9, A and B), which was 
associated with increased numbers of F. novicida bacteria re-
covered from infected Atg7 −/− BMDMs compared with the 
number recovered from infected WT BMDMs (Fig. 9 C).
To investigate whether the molecular mechanism or-
chestrated by cathepsin B to regulate autophagy and lyso-
somal biogenesis is recapitulated in a physiological setting, we 
analyzed signaling pathways in liver tissue homogenates from 
WT and Ctsb−/− mice. In agreement with our cellular anal-
yses, uninfected Ctsb−/− mice or those infected with F. novi-
cida exhibited a higher level of LC3-II compared with the 
corresponding WT controls (Fig. 9, D and E). Remarkably, 
LAMP1 expression was dramatically up-regulated in the liver 
of uninfected Ctsb−/− mice compared with uninfected WT 
mice, and both infected WT and Ctsb−/− mice maintained 
elevated levels of LAMP1 protein expression (Fig.  9  D). 
Moreover, expression of TFEB was significantly increased 
in Ctsb−/− mice (Fig. 9 F). In contrast, expression of Lcn2, 
a bacteriostatic factor produced during the innate immune 
response to bacterial infection, was similar in WT and Ctsb−/− 
mice after F. novicida infection (Fig.  9  F). Collectively, we 
identified a central role for cathepsin B in governing activi-
ties of TFEB and the kinase ULK1, resulting in suppression 
of lysosomal biogenesis and autophagy, respectively. Thus, the 
coordination of autophagy and lysosomal biogenesis induced 
by inhibition of cathepsin B facilitates host defense against F. 
novicida infection (Fig. 10).
DIS CUS SION
Lysosomal cathepsins have been conventionally recognized 
as executive proteases for cargo degradation and cell death. 
Our study identified a central role for cathepsin B in gov-
erning activities of TFEB and the kinase ULK1, resulting in 
suppression of lysosomal biogenesis and autophagy, respec-
tively. The involvement of cathepsin B in the lysosomal cell 
death pathway and activation of the NLRP3 inflammasome 
under certain physiological settings have attracted scientific 
interests (Tschopp and Schroder, 2010; Man and Kanneganti, 
2015). Our results, however, indicated that genetic deletion 
of cathepsin B is dispensable for activation of the AIM2 in-
flammasome, cytokine production, and cell death typically 
associated with F. novicida infection (Henry et al., 2007; Fer-
nandes-Alnemri et al., 2010; Jones et al., 2010; Rathinam et 
al., 2010; Man et al., 2015; Meunier et al., 2015), suggesting 
that there were additional roles of cathepsin B in host defense 
beyond inflammasome activation and cell death.
Figure 7. Cathepsin B regulates TRP ML1 
channel activity. (A) Immunoblot analysis of 
full-length TRP ML1 in WT and Ctsb−/− BMDMs. 
(B) Quantitative real-time PCR analysis of 
Trpml1 expression in WT and Ctsb−/− BMDMs. 
Hprt, hypoxanthine-guanine phosphoribosyl-
transferase; ns, not significant. (C) Immunoblot 
analysis of cleaved TRP ML1 in the whole cell 
lysate (WCL) or lysosomes purified from WT, 
Ctsb−/−, and immortalized Trpml1−/− BMDMs. 
LAMP1, cathepsin B, lamin B, and GAP DH were 
used as quality controls. (D) Lysosome cal-
cium release was analyzed in WT and Ctsb−/− 
BMDMs stimulated with 20 µM ML-SA1. Med, 
media. (E) Immunoblot analysis of TFEB in 
Ctsb−/− BMDMs treated with 0.1 µM TRP ML1 
inhibitor PI(4,5)P2 for the indicated times. 
(F) Quantification of data in E. (G) Immunoblot 
analysis of TFEB in Ctsb−/− BMDMs treated 
with 1 µM calcineurin inhibitor cyclosporin A 
for the indicated times. (H) Quantification of 
data in G. Data are representative of three in-
dependent experiments and are means ± SEM. 
*, P < 0.05; ***, P < 0.001.
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Figure 8. F. novicida infection induces autophagy formation and TFEB activation in macrophages. (A) Representative images of LC3-II+ puncta 
in uninfected (Med) WT and Ctsb−/− BMDMs or BMDMs infected with F. novicida for 4 h. (B) Quantification of the numbers of LC3-II+ puncta in WT and 
Ctsb−/− BMDMs with or without F. novicida infection. At least 200 cells were analyzed for each group. (C) Size of LC3-II+ puncta in WT and Ctsb−/− BMDMs in 
B. At least 100 cells were analyzed for each group. (D) Representative images of LC3-II+ puncta in WT and Ctsb−/− BMDMs infected with F. novicida for 4 h. 
Arrows indicate LC3-associated F. novicida; the arrowhead indicates LC3-II+ puncta free from F. novicida colocalization. At least 100 cells were analyzed in 
each group. (E) Confocal microscopy analysis of TFEB nuclear localization in WT and Ctsb−/− BMDMs with or without F. novicida infection. (F) Quantification 
of the percentage of TFEB nuclear localization. At least 200 cells were analyzed for each group. (G) Expression of the gene encoding TFEB was analyzed by 
quantitative real-time PCR. Hprt, hypoxanthine-guanine phosphoribosyltransferase. (H) Immunoblot analysis of LC3-II and TFEB and phosphorylation of 
ULK1, AMPK, and mTOR in uninfected WT and Ctsb−/− BMDMs or BMDMs infected with F. novicida for 3 h. (I) Quantification of the data in H. F. n, F. novicida; 
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In this study, we found a role for cathepsin B in neg-
atively regulating lysosomal biogenesis and autophagy, such 
that cells lacking cathepsin B possessed a superior ability to 
induce fusion of their lysosomes with F. novicida. It is also 
interesting to speculate that F. novicida might be engulfed by 
autophagosomes and require cathepsin B to mediate entry to 
the cytoplasm for further replication. In addition, it is possible 
that the localization of cathepsin B proteins to a particular 
location within the host cell might contribute to their ability 
to influence the number of bacteria in the host cell.
We found that genomic deletion of cathepsin B in 
mice did not confer protection against the vacuolar-adapted 
pathogen S. Typhimurium, which could be because of differ-
ences in the mechanisms used by this bacterium to evade the 
lysosomal degradation pathway or to the functional redun-
dancy among cathepsin proteases that are capable of induc-
ing degradation of S. Typhimurium (Diacovich and Gorvel, 
2010; Huang and Brumell, 2014). Further studies investigat-
ing the role of cytosolic pathogens, including both bacterial 
and viral pathogens, would yield insight into the biology of 
cathepsin B in infectious diseases. In particular, examining 
the effect of a range of doses of F. novicida infection in vivo 
would provide information on the strength of the impact of 
cathepsin B deletion (Nano et al., 2004; Kanistanon et al., 
2012; Chu et al., 2014).
The role of autophagy in the host defense against mem-
bers of the Francisella genus is controversial. The ability of 
different species or strains of the Francisella genus to evade 
the autophagy pathway might determine their intracellular 
survival (Chiu et al., 2009; Cremer et al., 2009; Chong et al., 
2012; Steele et al., 2013). Results from the ATG7-deficient 
BMDMs from our study suggested that canonical autophagy 
is protective in the host defense against F. novicida infection. 
Lysosomes play critical roles in nutrient sensing and energy 
homeostasis (Settembre et al., 2013). During infection, neu-
tralization of lysosomal pH by uropathogenic Escherichia coli 
in infected bladder epithelial cells can be sensed by the lyso-
somal cation channel TRP ML3, subsequently triggering ex-
pulsion of exosome-encased bacteria (Miao et al., 2015). Our 
study now reveals a critical role of cathepsin B in controlling 
activity of the key lysosomal Ca2+ channel TRP ML1. A lack of 
cathepsin B would leave the activity of TRP ML1 unchecked, 
and a previous study has demonstrated that Ca2+ release by 
lysosomes via TRP ML1 activates the phosphatase calcineurin, 
which, in turn, drives nuclear translocation of TFEB (Medina 
et al., 2015). Stressed signals from the lysosome itself might also 
inhibit mTOR activity and reduce phosphorylation of TFEB, 
leading to TFEB-dependent transcription of genes encoding 
molecules involved in lysosomal biogenesis and autophagy. 
The down-regulation of mTOR activity in Ctsb−/− BMDMs 
is consistent with a recent study showing that the mTORC1 
pathway is activated by lysosomal degradation (Palm et al., 
2015). It is not clear which specific signal elicited in the ab-
sence of cathepsin B down-regulated the phosphorylation of 
mTOR. However, enhanced AMPK phosphorylation in the 
absence of cathepsin B might provide a positive feedback re-
flecting increased lysosomal biogenesis, as this event occurred 
subsequent to TFEB and mTOR activation.
Our results unveiled a fundamental biological function 
of cathepsin B in providing a checkpoint for homeostatic 
maintenance of the lysosome population and basic recycling 
functions in the cell. Importantly, deficiency in cathepsin pro-
teases causes lysosome storage diseases in humans owing to 
accumulation of partially digested macromolecules and en-
larged lysosomes (Alroy and Lyons, 2014). TFEB-mediated 
lysosomal biogenesis and autophagy are crucial in exoge-
nous antigen presentation and cancer metabolism (Perera et 
al., 2015; Samie and Cresswell, 2015). Cathepsin B can also 
mediate trypsinogen activation to promote the development 
of acute pancreatitis (van Acker et al., 2002). Our findings 
suggested that cathepsin B is a negative regulator of lysosomal 
biogenesis and autophagy in the intracellular milieu during 
a microbial infection, which broadens the biological reper-
toire of this protease in the context of health and disease. Our 
study, therefore, raises the intriguing possibility that modu-
lating cathepsin B activity may hold therapeutic potential as 
a mean to increase host immunity against lethal F. novicida 
infection and to offer treatment options to those with debili-
tating lysosome storage diseases.
MAT ERI ALS AND MET HODS
Mice
WT C57BL/6J mice were purchased from The Jackson Lab-
oratory and bred in house. Ctsb−/− mice were provided by T. 
Reinheckel (Albert-Ludwigs-University Freiburg, Freiburg, 
Germany), generated as described previously (Halangk et al., 
2000), and backcrossed to the C57BL/6J background. Ctsg−/− 
(MacIvor et al., 1999) and Nepr3−/− (Kessenbrock et al., 2008) 
mice were provided by C. Pham (Washington University 
School of Medicine, St. Louis, MO). Aim2 −/− (Jones et al., 
2010) mice were provided by V.M. Dixit (Genentech, San Fran-
cisco, CA). LysM-Cre-Atg7 f/f mice were described previously 
(Martinez et al., 2011). Elastase−/− mice were purchased from 
The Jackson Laboratory (stock no. 006112; Belaaouaj et al., 
1998). All mutant mice were crossed with the C57BL/6J mice 
for >10 generations. All mice were kept in specific pathogen–
free conditions within the Animal Resource Center at St. Jude 
Children’s Research Hospital. Animal studies were conducted 
under protocols approved by the Institutional Animal Care and 
Use Committee of St. Jude Children’s Research Hospital.
ns, not significant. (J) ADP to ATP ratio analysis in uninfected WT and Ctsb−/− BMDMs or BMDMs infected with F. novicida for 1 h. Data are representative 
of two independent experiments (A–D) or three independent experiments (E–J). Data represent means ± SEM. Bars, 10 µm. *, P < 0.05; **, P < 0.01; ***, P < 
0.001; ****, P < 0.0001. ns, not significant.
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Bacterial culture and infection of mice
The bacterial strains used in this study were F. novicida strain 
U112, GFP-expressing F. novicida (from D.M. Monack, Stan-
ford University, Stanford, CA), and S. Typhimurium strain 
SL1344. F. novicida and S. Typhimurium were grown over-
night with shaking in tryptic soy broth (TSB) and Luria-Ber-
tani medium, respectively, subcultured for an additional 
3–4  h, and resuspended in PBS. 8–10-wk-old mice were 
injected subcutaneously with F. novicida U112 (1.5 × 105 
CFU per mouse) as described previously (Man et al., 2015). 
Mice were weighted and monitored daily over a period of 
3 wk. Mice were euthanized at days 1 and 3 after infection, 
Figure 9. Ctsb−/− mice have a greater capacity to induce autophagy 
and lysosomal biogenesis. (A) Immunoblot analysis of LC3 in uninfected 
and F. novicida (F.n.)–infected WT and Atg7−/− BMDMs. (B) Quantification 
of data in A. (C) BMDMs from WT and LysM-Cre-Atg7f/f mice were infected 
with F. novicida (MOI 10) for 3 h, and numbers of intracellular bacteria 
were enumerated at the indicated times. (D) Immunoblot analysis of LC3, 
LAMP1, cathepsin B, and GAP DH (loading control) in liver homogenates of 
uninfected WT and Ctsb−/− mice and mice infected with F. novicida for 1 d. 
(E) Quantification of data for LC3-II conversion in D. (F) Expression of the 
genes encoding TFEB and LCN2 in the liver of uninfected mice and mice 
infected with F. novicida for 1 d. Data are representative of three indepen-
dent experiments (A–C) or two independent experiments (D–F). Data rep-
resent means ± SEM. *, P < 0.05; **, P < 0.01. Hprt, hypoxanthine-guanine 
phosphoribosyltransferase; Med, media; ns, not significant; UI, uninfected.
Figure 10. A model of the regulation of lysosomal biogenesis and 
autophagy by cathepsin B in response to infection with F. novicida. 
(A) Cathepsin B mediates cleavage of the TRP ML1 channel and negatively 
regulates calcineurin (Cn) activity. (B) Deficiency in cathepsin B results in 
inhibition of mTOR activation owing to a stressed signal from the impaired 
lysosomal degradation. Both increased calcineurin and decreased mTOR 
activity in Ctsb−/− BMDMs drive nuclear translocation of TFEB, which in 
turn activates the transcription of genes associated with lysosome biogen-
esis and autophagy. (C) Stressed signals from the lysosome or a feedback 
signal from increased lysosomal biogenesis induces AMPK and ULK1 phos-
phorylation, which further activates the autophagy pathway. Thus, cathep-
sin B negatively regulates lysosomal biogenesis and autophagy at both the 
transcriptional and posttranslational levels. Increased lysosomal biogenesis 
and autophagy induced by cathepsin B deficiency results in effective clear-
ance of the intracellular bacterial pathogen F. novicida. Red arrow, induced 
or reduced activity; black arrow, activation; black line with bar head, inhi-
bition; solid line, activated; dash line, not activated.
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and liver and spleen were harvested to determine the bac-
terial burden. Liver and spleen were homogenized, serially 
diluted, plated onto TSB agar plates, and incubated overnight 
at 37°C as described previously (Man et al., 2015). For S. 
Typhimurium infection, mice were infected i.p. with 5 × 103 
CFU per mouse. For immune cell infiltration analysis, whole 
blood from WT and Ctsb−/− mice was analyzed on a hema-
tology analyzer (Forcyte; Oxford Sciences) by a hematologist 
blinded to the experimental groups.
Bacterial infection of macrophages
To generate BMDMs, BM cells were cultured in L929 cell–
conditioned IMDM supplemented with 10% FBS, 1% non-
essential amino acids, and 1% penicillin-streptomycin for 5 d. 
Immortalized BM-derived cells from Trpml1−/− mice used 
for controls were from H. Fares (University of Arizona, Tuc-
son, AZ; Miller et al., 2015). BMDMs were seeded in 12-well 
plates (1 million cells per well) and cultured overnight. The 
next day, cells were washed and supplied with fresh media 
without antibiotics. BMDMs were infected with F. novicida 
for the indicated times. For inhibitor treatment, BMDMs 
were treated with the cathepsin B inhibitor CA-074 Me (sc-
214647; Santa Cruz Biotechnology, Inc.), AMPK inhibitor 
compound C (171260; EMD Millipore), calcineurin inhibi-
tor cyclosporine A (PHR1092; Sigma-Aldrich), or lysosomal 
TRP ML1 inhibitor PI(4,5)P2 (R4504; Echelon Biosciences; 
Zhang et al., 2012). BMDMs were lysed in radioimmunopre-
cipitation assay buffer with protease and phosphatase inhibi-
tors (Roche) for immunoblot analysis.
Bacterial killing assay
BMDMs were infected with F. novicida with a multiplicity 
of infection (MOI) of 10 for 2 h and washed, and 50 µg/ml 
gentamicin was added to kill extracellular bacteria. After 1 h, 
cells were washed twice and cultured in fresh media. BMDMs 
were lysed in sterile water at the indicated times after infec-
tion, serially diluted, plated onto TSB agar plates, and incu-
bated overnight for CFU enumeration.
Preparation of liver sample for immunohistochemical 
staining and immunoblot analysis
Liver tissues were fixed in 10% formalin and embedded in 
paraffin for immunochemical staining. 4-µm–thick liver 
sections were stained with anti–cleaved caspase 3 or anti- 
myeloperoxidase (MPO) followed by incubation for 30 min 
with Rabbit-on-Rodent HRP polymer (RMR622; Bio-
Care Medical). TUN EL (terminal deoxynucleotidyl trans-
ferase deoxyuridine triphosphate nick end labeling) staining 
was performed with the Dead End kit (G7130) according to 
the manufacturer’s instructions (Promega). Liver tissues were 
homogenized in radioimmunoprecipitation assay buffer with 
protease and phosphatase inhibitors for immunoblot analy-
sis. Protein concentrations were determined using a bicin-
choninic acid assay kit (Thermo Fisher Scientific) according 
to manufacturer’s instructions.
Immunoblot analysis and antibodies
Samples were separated by 12% SDS-PAGE and followed 
by electrophoretic transfer onto polyvinylidene fluoride 
membranes as described previously (Karki et al., 2015). 
Membranes were blocked with 5% nonfat milk and further 
incubated overnight in primary antibody at 4°C. The follow-
ing primary antibodies were used: mouse IκBα, phosphory-
lated IκBα (p-IκBα; S32), ERK, p-ERK (T202Y204 [Cell 
signaling Technology], 9242L, 2859L, 9101L, and 9102L), 
anti–caspase 1 (AG-20B-0042; Adipogen), anti-LC3B 
(NB600-1384; Novus Biologicals), anti-LAMP1 (14-1071-
85; eBioscience), antibodies for caspase 3, 7, and 8 (9661S, 
9491S, and 8592S; Cell Signaling Technology), anti–cathep-
sin B (AF965; R&D Systems), antibodies for p-ULK1 (S555), 
total mTOR, p-mTOR (S2448), p–4E-BP1 (T37/46), total 
AMPK, p-AMPK (T172 [Cell Signaling Technology], 5869S, 
2972S, 5536S, 2855P, 2793S, and 2535P), anti-ULK1 (A7481; 
Sigma-Aldrich), anti-TFEB (A303-673A; Bethyl Labora-
tories, Inc.), anti-TRP ML1 (M1571; Sigma-Aldrich), anti- 
ATP6V1B2 (ab73404; Abcam), anti-MAR CKS (myristoylated 
alanine-rich C kinase substrate; ab51100; Abcam), anti–lamin 
B (SC-6216; Santa Cruz Biotechnology, Inc.), and anti-GAP 
DH (5174S; Cell Signaling Technology). The secondary an-
tibodies used were HRP-labeled anti–rabbit, anti–mouse, or 
anti–goat antibodies (Jackson ImmunoResearch Laboratories, 
Inc.). Quantification of the relative protein expression was 
processed using ImageJ (National Institutes of Health).
Immunofluorescence staining and microscopy
For LysoTracker staining and colocalization with F. novicida, 
WT and Ctsb−/− BMDMs were infected with GFP-expressing 
F. novicida and followed by labeling with 100 nM LysoTracker 
(L-7528; Molecular Probes) for the last 30 min. Cells were 
washed and fixed with 4% paraformaldehyde for 15 min at 
room temperature. Cells were washed three times and mounted 
using mounting medium (H-1200; Vector Laboratories). For 
LC3B, LAMP1, and TFEB immunostaining, uninfected and in-
fected BMDMs were fixed in 4% paraformaldehyde for 15 min 
at room temperature. Cells were then permeabilized with cold 
methanol for 5 min, washed with PBS, and blocked in 1× ELI 
SA buffer with 0.1% saponin for 1 h. Cells were stained with 
anti-LC3B (NB600-1384; Novus Biologicals), anti-LAMP1 
(14-1071-85; eBioscience), or anti-TFEB (A303-673A; Bethyl 
Laboratories, Inc.), all at 1:500 dilution, overnight at 4°C. Cells 
were washed, stained with fluorescence-conjugated second-
ary antibody for 1 h, and mounted using mounting medium 
(H-1200; Vector Laboratories). Cells were observed on a con-
focal microscope (Axio Observer; Z1; SlideBook 6 software; 
ZEI SS) for image acquisition and data analysis.
Transmission electron microscopy
BMDMs were fixed in 2% paraformaldehyde and 2.5% 
glutaraldehyde in 0.1  M cacodylate buffer (pH 7.4) 
for 1  h at 37°C. Cells were embedded and sectioned for 
transmission electron microscopy by the Cell and Tissue 
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Imaging Core Facility of St. Jude Children’s Research Hos-
pital. Quantification of lysosome and autophagosome size 
was performed with ImageJ.
Lysosome isolation
Lysosomes from BMDMs were isolated using a lysosome 
enrichment kit with cultured cell sonication and den-
sity gradient centrifugation, followed by lysosome precip-
itation according to the manufacturer’s manual (89839; 
Thermo Fisher Scientific). The purity of isolated ly-
sosomes was determined by detecting the lysosomal 
membrane protein LAMP1, luminal lysosomal protease 
cathepsin B, nuclear protein lamin B, and GAP DH using 
immunoblotting analysis.
Lysosome calcium release measurement
WT and Ctsb−/− BMDMs were labeled with a calcium in-
dicator (O-6807; Thermo Fisher Scientific) in calcium-free 
media for 15 min. Calcium release from the lysosome in-
duced by 20 µM ML-SA1 and 200 µM glycylphenylalanine 
2-naphthylamide was analyzed according to fluorescence in-
tensity at 488 nm recorded with a confocal imaging system as 
described previously (Shen et al., 2012).
ADP/ATP ratio assay
Both infected and uninfected WT and Ctsb−/− BMDMs 
were lysed in assay buffer, and ATP and ADP content were 
measured using an ADP/ATP ratio assay kit according to the 
manufacturer’s protocols (MAK135; Sigma-Aldrich).
Microarray analysis
Total RNA was extracted from WT and Ctsb−/− BMDMs, re-
verse transcribed into biotin-labeled cRNA with an Ambion 
WT Expression kit (Thermo Fisher Scientific), and hybrid-
ized to a Mouse Gene 2.0 ST GeneChip (Affymetrix). Gene 
expression data were normalized and transformed into log2 
transcript expression values with the robust multiarray aver-
age algorithm (version 6.6; Partek Genomics Suite; Irizarry et 
al., 2003). Differential expression was defined by application 
of a difference in expression of 0.5-fold (log2 signal) between 
conditions. The dataset has been deposited in the GEO data-
base under accession no. GSE79508.
Lactate dehydrogenase release assay
Cell culture supernatants were collected at the indicated 
times, and lactate dehydrogenase activity was measured 
by using the Promega cytotoxicity kit according to the 
manufacturer’s protocols.
ELI SA
Cell culture supernatant or sera from mice were analyzed for 
cytokine and chemokine release using a 22-multiplex assay 
(EMD Millipore) following the manufacturer’s instructions.
Real-time quantitative PCR
Total RNA was isolated from BMDMs using TRIzol (Invi-
trogen). cDNA was reverse transcribed by using Superscript 
III reverse transcriptase (Invitrogen). Real-time quantita-
tive PCR was performed on the ABI Prism 7500 sequence 
detection system (Applied Biosystems). Primer sequences 
are listed in Table S1.
Statistical analysis
Data are given as means ± SEM. Statistical analyses were per-
formed using one-way ANO VA with multiple comparisons, 
two-tailed Student t tests, and log-rank tests. P-values ≤0.05 
were considered significant.
Online supplemental material
Fig. S1 shows the expression of genes encoding TFEB, and its 
targets are differentially regulated in the absence of cathepsin 
B. Table S1 shows real-time quantitative PCR primer 
sequences. Online supplemental material is available at http 
://www .jem .org /cgi /content /full /jem .20151938 /DC1.
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